Gießen - Marburg - Langen
Infectious diseases are still one of the most frequent causes of death in the world. Even in industrialized countries, they are becoming a more serious threat due to increased resistance to antibiotics and emerging pathogens. The Gießen-Marburg-Langen location of DZIF will be tackling this very problem. The institutions involved are combining into DZIF their many years of expertise in infection research, drug development and drug approval, as well as their infrastructures such as the BSL-4 high-security laboratory in Marburg and the BSL-3 laboratory at the Paul-Ehrlich-Institut in Langen. Research activities are concentrated on developing strategies for combatting new or re-emerging infectious diseases in order to contain outbreaks of new pathogens by quick, effective action and rapid vaccine development. Marburg will be focusing on viral pathogens, while Gießen will be concentrating on bacteria and resistance to antibiotics.
The Technische Hochschule Mittelhessen – University of Applied Sciences – will be collaborating on implementing the results, producing identified active agents and vaccines in quality-assured processes for scientific and industrial partners. The Paul-Ehrlich-Institut (PEI) in Langen will be contributing its expertise in drug approval and development to ensure the research results are swiftly put into practice. Together with the Helmholtz Centre for Infection Research (HZI), PEI is significantly involved in the DZIF Production Development Unit (DZIF-PDU), where they analyze data from approval processes to identify critical factors that could unnecessarily delay a timely drug approval. The Gießen-Marburg-Langen location is involved in four Thematic Translational Units of DZIF (“Novel Anti-Infectives”, “HIV”, “Hepatitis” and “Healthcare-Associated and Antibiotic-Resistant Bacterial Infections”). The TTU “Emerging Infections”, which spans the 13 DZIF institutions, will be coordinated at Philipps-Universität Marburg. A bioinformatics centre shall furthermore be established for DZIF in Gießen in collaboration with the DZIF location Hannover-Braunschweig. The Institute of Medical Microbiology of Justus-Liebig-Universität is responsible for the overall coordination of the location.
Partner site speaker
Trinad Chakraborty (Justus-Liebig-Universität Gießen)
Deputy partner site speaker
Stephan Becker (Philipps-Universität Marburg)